• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性脑膜炎球菌病的流行病学与控制措施:评估框架

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.

作者信息

Caro J Jaime, Möller Jörgen, Getsios Denis, Coudeville L, El-Hadi Wissam, Chevat Catherine, Nguyen Van Hung, Caro Ingrid

机构信息

Caro Research Institute, Concord, MA, USA.

出版信息

BMC Public Health. 2007 Jun 29;7:130. doi: 10.1186/1471-2458-7-130.

DOI:10.1186/1471-2458-7-130
PMID:17603880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1925079/
Abstract

BACKGROUND

Meningococcal disease can have devastating consequences. As new vaccines emerge, it is necessary to assess their impact on public health. In the absence of long-term real world data, modeling the effects of different vaccination strategies is required. Discrete event simulation provides a flexible platform with which to conduct such evaluations.

METHODS

A discrete event simulation of the epidemiology of invasive meningococcal disease was developed to quantify the potential impact of implementing routine vaccination of adolescents in the United States with a quadrivalent conjugate vaccine protecting against serogroups A, C, Y, and W-135. The impact of vaccination is assessed including both the direct effects on individuals vaccinated and the indirect effects resulting from herd immunity. The simulation integrates a variety of epidemiologic and demographic data, with core information on the incidence of invasive meningococcal disease and outbreak frequency derived from data available through the Centers for Disease Control and Prevention. Simulation of the potential indirect benefits of vaccination resulting from herd immunity draw on data from the United Kingdom, where routine vaccination with a conjugate vaccine has been in place for a number of years. Cases of disease are modeled along with their health consequences, as are the occurrence of disease outbreaks.

RESULTS

When run without a strategy of routine immunization, the simulation accurately predicts the age-specific incidence of invasive meningococcal disease and the site-specific frequency of outbreaks in the Unite States. 2,807 cases are predicted annually, resulting in over 14,000 potential life years lost due to invasive disease. In base case analyses of routine vaccination, life years lost due to infection are reduced by over 45% (to 7,600) when routinely vaccinating adolescents 12 years of age at 70% coverage. Sensitivity analyses indicate that herd immunity plays an important role when this population is targeted for vaccination. While 1,100 cases are avoided annually when herd immunity effects are included, in the absence of any herd immunity, the number of cases avoided with routine vaccination falls to 380 annually. The duration of vaccine protection also strongly influences results.

CONCLUSION

In the absence of appropriate real world data on outcomes associated with large-scale vaccination programs, decisions on optimal immunization strategies can be aided by discrete events simulations such as the one described here. Given the importance of herd immunity on outcomes associated with routine vaccination, published estimates of the economic efficiency of routine vaccination with a quadrivalent conjugate vaccine in the United States may have considerably underestimated the benefits associated with a policy of routine immunization of adolescents.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b6/1925079/5eb6c32cc6e5/1471-2458-7-130-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b6/1925079/b8ac351c51af/1471-2458-7-130-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b6/1925079/22dde0a20ce9/1471-2458-7-130-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b6/1925079/5eb6c32cc6e5/1471-2458-7-130-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b6/1925079/b8ac351c51af/1471-2458-7-130-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b6/1925079/22dde0a20ce9/1471-2458-7-130-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b6/1925079/5eb6c32cc6e5/1471-2458-7-130-4.jpg
摘要

背景

脑膜炎球菌病可产生毁灭性后果。随着新疫苗的出现,有必要评估它们对公共卫生的影响。在缺乏长期真实世界数据的情况下,需要对不同疫苗接种策略的效果进行建模。离散事件模拟提供了一个灵活的平台来进行此类评估。

方法

开发了一种侵袭性脑膜炎球菌病流行病学的离散事件模拟,以量化在美国对青少年实施常规接种四价结合疫苗(预防A、C、Y和W-135血清群)的潜在影响。评估疫苗接种的影响,包括对接种个体的直接影响和群体免疫产生的间接影响。该模拟整合了各种流行病学和人口统计学数据,侵袭性脑膜炎球菌病发病率和疫情频率的核心信息来自疾病控制和预防中心提供的数据。对群体免疫产生的疫苗接种潜在间接益处的模拟借鉴了英国的数据,在英国,结合疫苗的常规接种已经实施了数年。对疾病病例及其健康后果进行建模,对疾病爆发的发生情况也进行建模。

结果

在没有常规免疫策略的情况下运行时,该模拟准确预测了美国侵袭性脑膜炎球菌病的年龄特异性发病率和特定地点的疫情频率。预计每年有2807例病例,因侵袭性疾病导致超过14000个潜在生命年损失。在常规疫苗接种的基础病例分析中,当对12岁青少年进行70%覆盖率的常规疫苗接种时,因感染导致的生命年损失减少超过45%(降至7600个)。敏感性分析表明,当针对该人群进行疫苗接种时,群体免疫起着重要作用。当纳入群体免疫效应时,每年可避免1100例病例,而在没有任何群体免疫的情况下,常规疫苗接种避免的病例数降至每年380例。疫苗保护的持续时间也对结果有很大影响。

结论

在缺乏与大规模疫苗接种计划相关结果的适当真实世界数据的情况下,离散事件模拟(如此处所述的模拟)可有助于做出关于最佳免疫策略的决策。鉴于群体免疫对与常规疫苗接种相关结果的重要性,美国已发表的关于四价结合疫苗常规接种经济效率的估计可能大大低估了青少年常规免疫政策带来的益处。

相似文献

1
Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.侵袭性脑膜炎球菌病的流行病学与控制措施:评估框架
BMC Public Health. 2007 Jun 29;7:130. doi: 10.1186/1471-2458-7-130.
2
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.美国青少年脑膜炎球菌结合疫苗补种活动的经济学分析
Clin Infect Dis. 2008 Jan 1;46(1):1-13. doi: 10.1086/524041.
3
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.意大利托斯卡纳常规普遍型和查漏补种型 C 群脑膜炎奈瑟菌疫苗接种策略对疾病发病率的影响。
Vaccine. 2012 Oct 5;30(45):6396-401. doi: 10.1016/j.vaccine.2012.08.019. Epub 2012 Aug 23.
4
Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.美国结合型脑膜炎球菌疫苗接种策略的成本效益
Pediatrics. 2005 May;115(5):1220-32. doi: 10.1542/peds.2004-2514.
5
Optimizing protection against meningococcal disease.优化针对脑膜炎球菌病的防护。
Clin Pediatr (Phila). 2010 Jun;49(6):586-97. doi: 10.1177/0009922809354327. Epub 2010 Jan 20.
6
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.美国的脑膜炎球菌病监测及结合型脑膜炎球菌疫苗的使用策略
Vaccine. 2001 Aug 14;19(31):4566-75. doi: 10.1016/s0264-410x(01)00209-2.
7
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.脑膜炎球菌携带、疾病及C群结合疫苗接种影响的动态模型
Am J Epidemiol. 2005 Jul 1;162(1):89-100. doi: 10.1093/aje/kwi160.
8
Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.意大利中部托斯卡纳地区脑膜炎奈瑟菌疫苗接种的现状与新展望
J Prev Med Hyg. 2012 Jun;53(2):61-7.
9
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).预防和控制脑膜炎球菌病:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28.
10
Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.用 4CMenB 和 MenACWY 对不同脑膜炎球菌疫苗接种策略对智利当前幼儿 MenACWY 国家免疫规划的公共卫生影响进行建模。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5603-5613. doi: 10.1080/21645515.2021.1996808. Epub 2021 Dec 10.

引用本文的文献

1
Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults.四价结合疫苗与美国青少年和青年人群侵袭性脑膜炎球菌病。
JAMA Netw Open. 2024 Nov 4;7(11):e2443551. doi: 10.1001/jamanetworkopen.2024.43551.
2
Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.脑膜炎球菌病暴发:一个不断变化的目标及常规预防性疫苗接种的理由
Infect Dis Ther. 2021 Dec;10(4):1949-1988. doi: 10.1007/s40121-021-00499-3. Epub 2021 Aug 11.
3
Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories.

本文引用的文献

1
Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation.不同免疫接种方案预防C群脑膜炎球菌病的相对效力:基于模型的评估
Vaccine. 2006 Apr 24;24(17):3500-4. doi: 10.1016/j.vaccine.2006.02.010. Epub 2006 Feb 21.
2
Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model.使用传播动力学模型重新评估C群脑膜炎球菌结合疫苗(MCC)的成本效益。
Med Decis Making. 2006 Jan-Feb;26(1):38-47. doi: 10.1177/0272989X05284109.
3
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
关于四价(A、C、Y、W135)脑膜炎球菌结合疫苗的使用建议,供各省和地区参考。
Can Commun Dis Rep. 2010 Jan 26;36(Suppl 2):1-35. doi: 10.14745/ccdr.v36i00as2.
4
Vaccine-related attitudes and decision-making among uninsured, Latin American immigrant mothers of adolescent daughters: a qualitative study.未参保、拉美裔移民母亲对少女女儿疫苗接种的态度和决策:一项定性研究。
Hum Vaccin Immunother. 2019;15(1):121-133. doi: 10.1080/21645515.2018.1514353. Epub 2018 Sep 13.
5
Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.加拿大使用单价和四价结合疫苗进行儿童脑膜炎球菌病免疫接种替代策略的成本效益分析。
PLoS One. 2017 May 4;12(5):e0175721. doi: 10.1371/journal.pone.0175721. eCollection 2017.
6
The impact of aggregating serogroups in dynamic models of Neisseria meningitidis transmission.在脑膜炎奈瑟菌传播动态模型中合并血清群的影响。
BMC Infect Dis. 2015 Jul 30;15:300. doi: 10.1186/s12879-015-1015-8.
7
Public health management of invasive meningococcal disease in Baden-Wuerttemberg, Germany, 2012: adherence to guidance and estimation of resources required as determined in a survey of local health authorities.2012年德国巴登-符腾堡州侵袭性脑膜炎球菌病的公共卫生管理:遵循指南并评估地方卫生当局调查确定所需的资源。
BMC Public Health. 2015 Apr 12;15:371. doi: 10.1186/s12889-015-1693-6.
8
Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia).法属南太平洋岛屿(新喀里多尼亚)侵袭性脑膜炎球菌感染的临床流行病学模式与补体缺陷之间的关系
J Clin Immunol. 2015 Jan;35(1):47-55. doi: 10.1007/s10875-014-0104-6. Epub 2014 Oct 29.
9
Development, theoretical framework, and evaluation of a parent and teacher-delivered intervention on adolescent vaccination.一项由家长和教师实施的青少年疫苗接种干预措施的开发、理论框架及评估
Health Promot Pract. 2014 Jul;15(4):556-67. doi: 10.1177/1524839913518222. Epub 2014 Jan 17.
10
Methodological concerns with economic evaluations of meningococcal vaccines.脑膜炎球菌疫苗经济学评价的方法学问题。
Pharmacoeconomics. 2010;28(6):449-61. doi: 10.2165/11535280-000000000-00000.
脑膜炎球菌携带、疾病及C群结合疫苗接种影响的动态模型
Am J Epidemiol. 2005 Jul 1;162(1):89-100. doi: 10.1093/aje/kwi160.
4
Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).脑膜炎球菌病的预防与控制。免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2005 May 27;54(RR-7):1-21.
5
Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.美国结合型脑膜炎球菌疫苗接种策略的成本效益
Pediatrics. 2005 May;115(5):1220-32. doi: 10.1542/peds.2004-2514.
6
Pharmacoeconomic analyses using discrete event simulation.使用离散事件模拟的药物经济学分析。
Pharmacoeconomics. 2005;23(4):323-32. doi: 10.2165/00019053-200523040-00003.
7
Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.荷兰C群脑膜炎球菌结合疫苗接种计划的经济学评估及其对决策的影响。
Vaccine. 2004 Dec 9;23(4):470-9. doi: 10.1016/j.vaccine.2004.06.019.
8
Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research.评估工业化国家中脑膜炎奈瑟菌疫苗接种的经济学:综述及进一步研究建议
Int J Technol Assess Health Care. 2004 Summer;20(3):280-8. doi: 10.1017/s0266462304001096.
9
Neisseria meningitidis: an overview of the carriage state.脑膜炎奈瑟菌:携带状态概述
J Med Microbiol. 2004 Sep;53(Pt 9):821-832. doi: 10.1099/jmm.0.45529-0.
10
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.引入4年后的C群脑膜炎球菌结合疫苗的效力
Lancet. 2004;364(9431):365-7. doi: 10.1016/S0140-6736(04)16725-1.